Efpeglenatide has proven to significantly reduce several risk factors for cardiovascular and kidney disease.
Read More »Linagliptin and Glimepiride
According to current research, linagliptin had a significantly lower risk of hypoglycemia and adverse events in geriatric patients with type 2 diabetes.
Read More »Risk of Herpes Zoster in Patients with Diabetes
A systematic review found patients with diabetes were associated with a 38% increased risk of developing herpes zoster.
Read More »Cannabis Use in Type 2 Diabetes
Could cannabis and/or CBD usage have an impact on type 2 diabetes, for good or ill?
Read More »Incidence of Proliferative Diabetic Retinopathy at 5 years After T2D
How do factors such as insulin use and blood glucose control impact the overall risk of developing diabetic complications 5 years after type 2 diagnosis?
Read More »The Effect of Type 2 Diabetes on Cognitive Function in Middle-Aged Patients
Could midlife cognitive decline be an indicator of increased dementia risk in patients with type 2 diabetes?
Read More »Religion and Spirituality Not Significantly Associated with Reduced Incidence of T2D
Women who attended religious service had a similar incidence of T2D compared to those that did not.
Read More »Narrowing the Scope of Antidiabetic Treatment Options Utilizing Patient-Specific Factors
The abundant options for glucose-lowering medications can make an individualized pharmacologic approach to treatment arduous.
Read More »COVID-19 ICU Admissions in Patients with Diabetes
Recent studies show a correlation between patients with diabetes and ICU admissions/mechanical ventilation for COVID-19 infections in the United States.
Read More »Different Groups of People at Risk for Developing T2D
Researchers examined six different subgroups to determine what factors raised or lowered their risk of developing type 2 diabetes.
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.